News
More than 35,000 cases of the mosquito-borne disease have been reported on the French Indian Ocean island since August 2024.
The newly identified deer, a 4.5-year-old white-tailed buck, was harvested by a landowner helping the DNR with ongoing ...
French President Emmanuel Macron has promised more support to fight chikungunya on La Réunion, after a baby died from the ...
The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...
Six people have died from chikungunya on the French overseas department of Réunion Island since the start of the year, health ...
Financially, Valneva SE reported €163.3 million in revenue for 2024 with positive cash flow. See why I rate VALN stock as a ...
Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $17.08, a high estimate of ...
Valneva has received marketing authorisation from the Brazilian Health Regulatory Agency (ANVISA) for its single-dose ...
SE ADR (NASDAQ:VALN) stock closed up 12.1% following the announcement that the Brazilian Health Regulatory Agency (ANVISA) has granted the first marketing authorization for its chikungunya vaccine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results